- Home
- LXFR vs VRCA Comparison
LXFR vs VRCA Comparison
Compare LXFR & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXFR
- VRCA
- Stock Information
- Founded
- LXFR 1898
- VRCA 2013
- Country
- LXFR United States
- VRCA United States
- Employees
- LXFR N/A
- VRCA N/A
- Industry
- LXFR Major Chemicals
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- LXFR Industrials
- VRCA Health Care
- Exchange
- LXFR Nasdaq
- VRCA Nasdaq
- Market Cap
- LXFR 370.4M
- VRCA 363.1M
- IPO Year
- LXFR 2012
- VRCA 2018
- Fundamental
- Price
- LXFR $13.09
- VRCA $0.68
- Analyst Decision
- LXFR
- VRCA Hold
- Analyst Count
- LXFR 0
- VRCA 5
- Target Price
- LXFR N/A
- VRCA $6.00
- AVG Volume (30 Days)
- LXFR 128.8K
- VRCA 707.2K
- Earning Date
- LXFR 02-25-2025
- VRCA 11-04-2024
- Dividend Yield
- LXFR 3.97%
- VRCA N/A
- EPS Growth
- LXFR 57.96
- VRCA N/A
- EPS
- LXFR 0.34
- VRCA N/A
- Revenue
- LXFR $384,400,000.00
- VRCA $9,210,000.00
- Revenue This Year
- LXFR N/A
- VRCA $54.16
- Revenue Next Year
- LXFR $3.44
- VRCA $99.78
- P/E Ratio
- LXFR $41.31
- VRCA N/A
- Revenue Growth
- LXFR N/A
- VRCA 187.45
- 52 Week Low
- LXFR $7.55
- VRCA $0.61
- 52 Week High
- LXFR $15.64
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- LXFR 39.73
- VRCA 34.87
- Support Level
- LXFR $12.87
- VRCA $0.62
- Resistance Level
- LXFR $13.42
- VRCA $0.73
- Average True Range (ATR)
- LXFR 0.45
- VRCA 0.09
- MACD
- LXFR -0.08
- VRCA -0.00
- Stochastic Oscillator
- LXFR 14.19
- VRCA 16.70
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.